Balchem Co. (NASDAQ:BCPC) Shares Sold by Corient Private Wealth LLC

Corient Private Wealth LLC lowered its position in shares of Balchem Co. (NASDAQ:BCPC - Free Report) by 0.7% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 254,192 shares of the basic materials company's stock after selling 1,800 shares during the quarter. Corient Private Wealth LLC owned about 0.78% of Balchem worth $41,432,000 at the end of the most recent quarter.

A number of other large investors also recently bought and sold shares of the company. Westside Investment Management Inc. acquired a new position in shares of Balchem in the 3rd quarter valued at about $27,000. R Squared Ltd bought a new position in Balchem in the fourth quarter worth about $29,000. Wilmington Savings Fund Society FSB acquired a new position in Balchem in the third quarter valued at approximately $35,000. Venturi Wealth Management LLC bought a new position in shares of Balchem during the fourth quarter valued at approximately $95,000. Finally, Smartleaf Asset Management LLC raised its position in shares of Balchem by 230.8% during the 4th quarter. Smartleaf Asset Management LLC now owns 645 shares of the basic materials company's stock worth $106,000 after purchasing an additional 450 shares during the period. Institutional investors own 87.91% of the company's stock.

Analyst Upgrades and Downgrades

BCPC has been the subject of a number of analyst reports. HC Wainwright restated a "buy" rating and set a $190.00 price objective on shares of Balchem in a research report on Monday, February 24th. StockNews.com downgraded shares of Balchem from a "buy" rating to a "hold" rating in a report on Tuesday, February 25th. Finally, Sidoti raised shares of Balchem to a "hold" rating in a report on Tuesday, February 25th.

Remove Ads

Balchem Stock Performance

Shares of NASDAQ BCPC traded down $2.23 during midday trading on Friday, hitting $161.17. 758,211 shares of the company's stock were exchanged, compared to its average volume of 113,912. Balchem Co. has a twelve month low of $137.69 and a twelve month high of $186.03. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.99 and a quick ratio of 1.16. The firm has a market cap of $5.24 billion, a P/E ratio of 41.01, a PEG ratio of 4.41 and a beta of 0.63. The stock's 50 day moving average price is $164.57 and its 200-day moving average price is $169.54.

Balchem (NASDAQ:BCPC - Get Free Report) last announced its quarterly earnings results on Friday, February 21st. The basic materials company reported $1.03 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.11 by ($0.08). The business had revenue of $240.00 million for the quarter, compared to analyst estimates of $239.96 million. Balchem had a return on equity of 11.37% and a net margin of 13.47%. Equities research analysts anticipate that Balchem Co. will post 4.64 EPS for the current year.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.